
News|Podcasts|November 10, 2022 (Updated: October 13, 2023)
An Invitation to Define the Lab of the Future
Author(s)LabVantage Solutions
Today’s labs are not sufficient to handle tomorrow’s challenges. What will labs in 2030 or 2040 look like? Mikael Hagstroem, CEO at LabVantage Solutions and expert in harnessing data and analytics, discusses the three phases of digital transformation needed to reimagine business models, achieve better performance, and create long-term sustainable advantage. It starts with changing our labs – the technologies, processes, ways of working, and data solutions.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content





The Transformative Role of Medical Information in Customer Engagement
ByIndegene
Published: | Updated:
Trending on PharmExec
1
FDA Approves Hernexeos Under National Priority Voucher Program
2
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
3
Pharmaceutical Executive Daily: FDA Approves Hernexeos
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5
